Aspyra To Delist Stock

Westlake Village-based Aspyra said Tuesday afternoon that the firm is voluntarily delisting its common stock from the AMEX. The firm, which is listed at APY, said it intends to deslist due to limited trading in its common stock, the costs of preparing and filing reports with the SEC, and because the typical advantages of being a public company--including access to capital and use of equity to acquire other businesses--is not currently sufficiently available to justify continued listing. The firm said its stock will no longer trade on any other exchange after the delisting. Aspyra is a provider of health care information technology services and products, specifically clinical information systems and archiving products for hospitals, clinics, laboratories, and others.